BCLI — Brainstorm Cell Therapeutics Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.86 Analyst target: $17.00 Upside: 1876.51%

See the full interactive analysis & chart →

Informational only — not investment advice.